» Articles » PMID: 23266512

Expression of Glucose Transporters in Cancers

Overview
Specialties Biochemistry
Biophysics
Date 2012 Dec 26
PMID 23266512
Citations 216
Authors
Affiliations
Soon will be listed here.
Abstract

It has been known for 80 years that cancer cell growth in an energy-related process supported by an increased glucose metabolism. This phenomenon suggests a need for a corresponding increased uptake of glucose across the plasma membrane through an enhancement in the glucose transporter proteins, SGLT proteins as well as GLUT proteins. The results of many studies have demonstrated that the expression of glucose transporters, especially GLUT1, is increased in a variety of malignancies. GLUT1 overexpression has been found to be associated with tumor progression. It was found that GLUT1 overexpression is associated with poor overall survival in various malignant tumors.

Citing Articles

Metabolic adaptations to acute glucose uptake inhibition converge upon mitochondrial respiration for leukemia cell survival.

Komza M, Khatun J, Gelles J, Trotta A, Abraham-Enachescu I, Henao J Cell Commun Signal. 2025; 23(1):47.

PMID: 39863913 PMC: 11762851. DOI: 10.1186/s12964-025-02044-y.


Momordicine-I suppresses head and neck cancer growth by modulating key metabolic pathways.

Bandyopadhyay D, Tran E, Patel R, Luetzen M, Cho K, Shriver L Cell Commun Signal. 2024; 22(1):597.

PMID: 39696286 PMC: 11657802. DOI: 10.1186/s12964-024-01951-w.


- Challenges and Perspectives in Polyelectrolytes.

Traeger A, Leiske M Biomacromolecules. 2024; 26(1):5-32.

PMID: 39661745 PMC: 11733940. DOI: 10.1021/acs.biomac.4c01061.


A novel approach to regulate glucose uptake in an anaplastic thyroid cancer cell line.

Heydarzadeh S, Moshtaghie A, Daneshpour M, Hedayati M Endocr Connect. 2024; .

PMID: 39555605 PMC: 11728915. DOI: 10.1530/EC-24-0336.


Design and development of nanoprobes radiolabelled with Tc for the diagnosis and monitoring of therapeutic interventions in oncology preclinical research.

Salgueiro M, Portillo M, Tesan F, Nicoud M, Medina V, Moretton M EJNMMI Radiopharm Chem. 2024; 9(1):74.

PMID: 39470937 PMC: 11522242. DOI: 10.1186/s41181-024-00300-z.